|
SDF2L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.05609998524159E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.771300E-04 |
| Normal-vs-Stage2 |
3.202100E-03 |
| Normal-vs-Stage3 |
6.87789999953559E-07 |
| Normal-vs-Stage4 |
1.84120000357169E-08 |
| Stage1-vs-Stage2 |
2.280800E-01 |
| Stage1-vs-Stage3 |
1.046150E-01 |
| Stage1-vs-Stage4 |
8.027000E-04 |
| Stage2-vs-Stage3 |
8.731000E-01 |
| Stage2-vs-Stage4 |
1.642840E-01 |
| Stage3-vs-Stage4 |
3.899800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.87100004565156E-09 |
| Normal-vs-AfricanAmerican |
1.081540E-03 |
| Normal-vs-Asian |
4.008300E-02 |
| Caucasian-vs-AfricanAmerican |
1.763610E-01 |
| Caucasian-vs-Asian |
8.701000E-01 |
| AfricanAmerican-vs-Asian |
2.547600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.20020000005105E-06 |
| Normal-vs-Female |
6.30230001519294E-09 |
| Male-vs-Female |
5.974100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.320000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.65198999999561E-05 |
| Normal-vs-Age(61-80Yrs) |
1.97049999650645E-08 |
| Normal-vs-Age(81-100Yrs) |
7.172000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.390400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.267200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.868400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.902040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.769000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.756800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.533000E-01 |
| Normal-vs-Grade 2 |
8.123900E-03 |
| Normal-vs-Grade 3 |
1.43630000115635E-08 |
| Normal-vs-Grade 4 |
7.18950010636377E-10 |
| Grade 1-vs-Grade 2 |
5.096600E-01 |
| Grade 1-vs-Grade 3 |
1.037550E-01 |
| Grade 1-vs-Grade 4 |
6.301900E-03 |
| Grade 2-vs-Grade 3 |
3.379400E-03 |
| Grade 2-vs-Grade 4 |
1.92260000031474E-07 |
| Grade 3-vs-Grade 4 |
3.901400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.137600E-03 |
| Normal-vs-ccB subtype |
1.81960000000814E-06 |
| ccA subtype-vs-ccB subtype |
2.871900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.2301000003373E-07 |
| Normal-vs-N1 |
4.356400E-03 |
| N0-vs-N1 |
4.582200E-01 |
|
|
